Company Search:
Advanced Search
Sponsored Links
4d Pharma Plc Company Snapshot
4d Pharma Plc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares 4d Pharma Plc with three other companies in this sector in UNITED KINGDOM : Reneuron Group PLC (2019 sales of £49,000.00 [US$63,801.92 ] of which 100% was Cell-Based Therapies), Immupharma PLC (£77,925.00 [US$101,464.58 ] of which 100% was Pharmaceutical Research & Development), and Silence Therapeutics Plc (£244,000.00 [US$317,707.52 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
4d Pharma Plc
  Stock Performance Chart for 4d Pharma Plc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 133.50p
(Figures in Pounds Sterling)
1 Week 39.4%   13 Weeks -19.8%  
4 Weeks 197.3%   52 Weeks 36.9%  
4d Pharma Plc Key Data:
  Ticker: DDDD Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 211,000
(Year Ending Jan 2020).
Employees: 127
  Currency: Pounds Sterling Market Cap: 130,359,663
  Fiscal Yr Ends: December Shares Outstanding: 97,647,688
  Share Type: Ordinary Closely Held Shares: 58,621,171
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.